Literature DB >> 7722457

H-2M3a violates the paradigm for major histocompatibility complex class I peptide binding.

J M Vyas1, J R Rodgers, R R Rich.   

Abstract

The major histocompatibility (MHC) class I-b molecule H-2M3a binds and presents N-formylated peptides to cytotoxic T lymphocytes. This requirement potentially places severe constraints on the number of peptides that M3a can present to the immune system. Consistent with this idea, the M3a-Ld MHC class I chimera is expressed at very low levels on the cell surface, but can be induced significantly by the addition of specific peptides at 27 degrees C. Using this assay, we show that M3a binds many very short N-formyl peptides, including N-formyl chemotactic peptides and canonical octapeptides. This observation is in sharp contrast to the paradigmatic size range of peptides of 8-10 amino acids binding to most class I-a molecules and the class I-b molecule Qa-2. Stabilization by fMLF-benzyl amide could be detected at peptide concentrations as low as 100 nM. While N-formyl peptides as short as two amino acids in length stabilized expression of M3a-Ld, increasing the length of these peptides added to the stability of peptide-MHC complexes as determined by 27-37 degrees C temperature shift experiments. We propose that relaxation of the length rule may represent a compensatory adaptation to maximize the number of peptides that can be presented by H-2M3a.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722457      PMCID: PMC2191989          DOI: 10.1084/jem.181.5.1817

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  49 in total

1.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.

Authors:  H C Guo; T S Jardetzky; T P Garrett; W S Lane; J L Strominger; D C Wiley
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

2.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

3.  Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide.

Authors:  M Schulz; P Aichele; R Schneider; T H Hansen; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

4.  Mutational analysis of regulation of MHC and anti-viral genes.

Authors:  J R Rodgers; P R Wyde; R R Rich
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

5.  A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes.

Authors:  M J Reddehase; J B Rothbard; U H Koszinowski
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

Review 6.  The molecular biology of leukocyte chemoattractant receptors.

Authors:  P M Murphy
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  A subset of HLA-B27 molecules contains peptides much longer than nonamers.

Authors:  R G Urban; R M Chicz; W S Lane; J L Strominger; A Rehm; M J Kenter; F G UytdeHaag; H Ploegh; B Uchanska-Ziegler; A Ziegler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

8.  Biochemical specificity of H-2M3a. Stereospecificity and space-filling requirements at position 1 maintain N-formyl peptide binding.

Authors:  J M Vyas; S M Shawar; J R Rodgers; R G Cook; R R Rich
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

9.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

10.  Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  5 in total

1.  Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP).

Authors:  P Anton; J O'Connell; D O'Connell; L Whitaker; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

2.  Interferon-gamma increases hPepT1-mediated uptake of di-tripeptides including the bacterial tripeptide fMLP in polarized intestinal epithelia.

Authors:  Marion Buyse; Laetitia Charrier; Shanthi Sitaraman; Andrew Gewirtz; Didier Merlin
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

3.  Cotton rat Sihi-M3 is a minimally oligomorphic Mhc I-b molecule that binds the chemotactic peptide fMLF under stringent conditions. Evidence that positive selection drives inter-species diversity of residues interacting with the termini of short peptides.

Authors:  C Kuyler Doyle; Richard G Cook; Robert R Rich; John R Rodgers
Journal:  Immunogenetics       Date:  2003-08-27       Impact factor: 2.846

4.  Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3.

Authors:  L L Lenz; B Dere; M J Bevan
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

5.  H2-M3 restricted presentation of a Listeria-derived leader peptide.

Authors:  M F Princiotta; L L Lenz; M J Bevan; U D Staerz
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.